FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35499011000001104: Lynparza 150mg tablets (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107104501000001116 Lynparza 150mg tablets (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107104601000001117 Lynparza 150mg tablets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lynparza 150mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Is a Olaparib 150mg tablets true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Has active ingredient Olaparib true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Has specific active ingredient Olaparib true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Is a Lynparza true Inferred relationship Existential restriction modifier
Lynparza 150mg tablets (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lynparza 150mg tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has AMP True Lynparza 150mg tablets (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start